Cogent Biosciences (COGT) Enterprise Value: 2017-2021
Historic Enterprise Value for Cogent Biosciences (COGT) over the last 4 years, with Dec 2021 value amounting to $341.9 million.
- Cogent Biosciences' Enterprise Value rose 397.80% to $341.9 million in Q4 2021 from the same period last year, while for Dec 2021 it was $341.9 million, marking a year-over-year increase of 215.83%. This contributed to the annual value of $861.6 million for FY2024, which is 70.14% up from last year.
- Latest data reveals that Cogent Biosciences reported Enterprise Value of $341.9 million as of Q4 2021, which was up 158.56% from $132.2 million recorded in Q3 2021.
- In the past 5 years, Cogent Biosciences' Enterprise Value ranged from a high of $341.9 million in Q4 2021 and a low of -$114.8 million during Q4 2020.
- Moreover, its 3-year median value for Enterprise Value was $10.7 million (2019), whereas its average is $46.3 million.
- In the last 5 years, Cogent Biosciences' Enterprise Value crashed by 2,204.38% in 2020 and then surged by 1,432.89% in 2021.
- Over the past 5 years, Cogent Biosciences' Enterprise Value (Quarterly) stood at -$49.6 million in 2017, then surged by 168.59% to $34.0 million in 2018, then crashed by 145.11% to -$15.3 million in 2019, then tumbled by 648.44% to -$114.8 million in 2020, then soared by 397.80% to $341.9 million in 2021.
- Its Enterprise Value was $341.9 million in Q4 2021, compared to $132.2 million in Q3 2021 and $93.4 million in Q2 2021.